By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Glaukos Corporation 

26061 Merit Circle
Suite 101
Laguna Hills  California  92653  U.S.A.
Phone: 949-367-9600 Fax:



Start Up

Company News
Combining Implantation Of Glaukos Istent Inject Trabecular Micro-Bypass With Topical Travoprost Provides Sustained IOP Reduction And Favorable Safety Profile, According To New Study 6/21/2017 6:28:27 AM
Study Reveals Potential Cost Efficiency Of Using Two Glaukos Istent Trabecular Micro-Bypass Stents To Treat Elevated IOP In Glaucoma Patients 5/23/2017 5:19:44 AM
Glaukos Announces First Quarter 2017 Financial Results 5/4/2017 7:04:22 AM
Glaukos Completes Patient Enrollment In Phase II Clinical Trial For iDose Travoprost Intraocular Implant In Glaucoma Patients 5/3/2017 6:46:15 AM
Glaukos To Release First Quarter 2017 Financial Results After Market Close On May 3 4/19/2017 11:00:17 AM
Glaukos Acquires IOP Sensor System From Dose Medical 4/13/2017 6:47:04 AM
International Study Shows Two Glaukos Istent Trabecular Micro-Bypass Stents And One Topical Medication Deliver Sustained IOP Reduction 4/13/2017 6:24:57 AM
Why SoCal's Glaukos' Revenue Could Fall 30% in the Next Year 4/10/2017 6:58:37 AM
Glaukos Announces Five-Year Extensions For Three Category III CPT Codes Related To Micro-Invasive Glaucoma Surgery 3/16/2017 8:39:51 AM
Glaukos Stock Notches Gains With Eye-Popping Results 3/3/2017 5:50:45 AM